510(k) K043303

Device
ONLINE DAT PROPOXYPHENE PLUS
Applicant
ROCHE DIAGNOSTICS CORP.
510(k) number
K043303
Product code
JXN  
Decision
Substantially Equivalent (SESE)
Decision date
2005-03-11
Date received
2004-11-30
Regulation
862.3700
Classification name
Enzyme Immunoassay, Propoxyphene
Medical specialty
Toxicology
Review panel
Toxicology
Device class
2
Clearance type
Traditional
Statement or summary
Summary
Third party reviewed
No

Applicant Contact#

Contact
KERWIN KAUFMAN
Address
9115 Hague Rd. Indianapolis IN US 46250 46250

FDA Registration Numbers#

Source Documents#

510(k) summary PDF

Other 510(k) Records For Product Code JXN  #

510(k), Device, Applicant table
510(k)DeviceApplicantDecision date
K152495Wondfo Propoxyphene Urine TestGuangzhou Wondfo Biotech Co., Ltd.2015-11-23
K122752FASTECT II PPX DRUG SCREEN DIPSTICK, FASTECT II DRUG SCREEN DIPSTICK, QUICKTOX DRUG SCREEN DIPCARDBranan Medical Corp.2013-01-30
K111363PPX REAGENT, PPX CALIBRATORS, PPX QC MATERIALMedica Corp.2011-12-06
K040445ACON PPX ONE STEP PROPOXYPHENE TEST STRIP AND ACON PPX STEP PROPOXYPHENE TEST DEVICEACON Laboratories, Inc.2004-05-19
K030835'RAPID ONE' - PROPOXYPHENE TESTAmerican Bio Medica Corp.2003-05-22
K023795PROPOXYPHENE ENZYME IMMUNOASSAY, CATALOG #0120 (500 TEST KIT), #0121 (5000 TEST KIT)Lin-Zhi International, Inc.2003-01-21
K022915INSTANT-VIEW PROPOXYPHENE (PPX) URINE TESTAlfa Scientific Designs, Inc.2002-11-29
K020787VERDICT-II PROPOXYPHENEMedtox Diagnostics, Inc.2002-05-02
K013100PROPOXYPHENEAbbott Laboratories2002-03-20
K011163MODIFICATION TO THE EMIT II PLUS PROPOXYPHENE ASSAY, MODEL OSR9G229Syva Co., Dade Behring, Inc.2001-05-10
K993981SYVA EMIT II PLUS PROPOXYPHENE ASSAY, MODELS 9G029UL/9G129ULSyva Co.2000-02-01
K983700MODIFICATION TO ABUSCREEN ONLINE FOR PROPOXYPHENERoche Diagnostic Systems, Inc.1998-12-11
K955675SYNCHRON SYSTEMS PROPOXYPHENE REAGENTBeckman Instruments, Inc.1996-02-09
K951133CEDIA DAU PROPOXYPHENE ASSAYMicrogenics Corp.1995-05-02
K944372STC DIAGNOSTIC AUTO-LYTE PROPOXYPHENE EIASolarcare, Inc.1995-02-08

Legacy Summary#

summary

FDA Review#

Decision Summary